Anxiolytic-like effect of 2-(4-((1-phenyl-1H -pyrazol-4-yl)methyl)piperazin-1-yl)ethan-1-ol is mediated through the benzodiazepine and nicotinic pathways-Reference-Cited by-同舟云学术

Anxiolytic-like effect of 2-(4-((1-phenyl-1H -pyrazol-4-yl)methyl)piperazin-1-yl)ethan-1-ol is mediated through the benzodiazepine and nicotinic pathways

Published:2017-03-06 Issue:3 Volume:90 Page:432-442
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Brito Adriane F.¹,Fajemiroye James O.¹,Neri Hiasmin F. S.¹,Silva Dayane M.¹,Silva Daiany P. B.¹,Sanz Germán²,Vaz Boniek G.²,de Carvalho Flávio S.³,Ghedini Paulo C.¹,Lião Luciano M.³,Menegatti Ricardo⁴,Costa Elson A.¹^ORCID

Affiliation:

1. Department of Pharmacology; ICB; Federal University of Goiás; Goiânia GO Brazil

2. Chemistry Institute; Laboratory of Chromatography and Mass Spectrometry; Federal University of Goiás; Goiânia GO Brazil

3. Chemistry Institute; Federal University of Goias; Goiânia GO Brazil

4. Faculty of Pharmacy; Laboratory of Medicinal Pharmaceutical Chemistry; Federal University of Goiás; Goiânia GO Brazil

Funder

Universidade Federal de Goiás

Fundação de Amparo à Pesquisa do Estado de Goiás

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cbdd.12961/fullpdf

Reference43 articles.

1. NIH - National Institute of Mental Health. 2016 Anxiety disorders http://www.nimh.nih.gov/health/topics/anxiety-disorders/index.shtml

2. CBHSQ - Center for Behavioral Health Statistics and Quality 2015 Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health http://www.samhsa.gov/data/

3. PhRMA 2014 Medicines in Development for Mental Health http://www.phrma.org/sites/default/files/pdf/2014-mental-health-report.pdf

4. PhRMA 2016 Medicines in Development for Mental Illnesses. 2016 Update http://phrma.org/sites/default/files/pdf/medicines-in-development-report-mental-illnesses.pdf

5. WHO - World Health Organization Regional Office for Europe 2013 RC 63 fact sheet on mental health http://www.euro.who.int/__data/assets/pdf_file/0004/215275/RC63-Fact-sheet-MNH-Eng.pdf

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphism and Pharmacological Assessment of Carbamazepine;International Journal of Molecular Sciences;2024-09-11

2. Neuropharmacological Potential of Different Piperazine Analogs: A Recent Prospective;Mini-Reviews in Organic Chemistry;2024-01-16

3. Preclinical data on morpholine (3,5-di-tertbutyl-4-hydroxyphenyl) methanone induced anxiolysis;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-04-25

4. LQFM212, a piperazine derivative, exhibits potential antioxidant effect as well as ameliorates LPS-induced behavioral, inflammatory and oxidative changes;Life Sciences;2023-01

5. The Neuropharmacological Potential of Piperazine Derivatives: A Mini- Review;Mini-Reviews in Organic Chemistry;2022-11